Clinical trial
Interferon Alfa or No Further Therapy Following Surgery in Treating Patients…
NCT00002892 · Institute of Cancer Research, United Kingdom, Other · Completed
Key facts
| NCT number | NCT00002892 |
|---|---|
| Title | Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma |
| Official title | A RANDOMISED STUDY OF OBSERVATION VERSUS ADJUVANT LOW DOSE EXTENDED DURATION INTERFERON ALPHA-2A IN COMPLETELY RESECTED HIGH RISK MALIGNANT MELANOMA |
| Lead sponsor | Institute of Cancer Research, United Kingdom, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological |
| Interventions | recombinant interferon alfa |
| Enrollment | 1,000 |
| Start date | Oct 1, 1995 |
| Completion | Dec 1, 2001 |
| First posted | May 13, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: